Channelling gene silencing to cure disease.
Our mission is to use our technology to create a new generation of therapeutics which can improve outcomes for patients and, in the process, build shareholder value.
Silence Therapeutics strives to conduct its business in an ethical, responsible and transparent manner.
Our management team is highly experienced in a variety of relevant sectors, from molecular biology and genetics to finance and investment banking.
Our Board of Directors is formed by six accomplished members, two Executive and four Non-Executive Directors.
As the RNA field evolves at an ever-faster rate, our TAB helps us to assess its competitive position in technology and offers guidance in developing it in the most effective way.
We offer a vibrant culture and environment where innovation and creativity is encouraged.
Download the Cowen Healthcare March 2018 presentation here
Our technology is a highly specific and modular platform that enables us to inhibit or ‘silence’ the expression of disease-causing genes, allowing cells to revert to their healthy state.
We are committed to creating collaborations that maximise value for each of the partners.
We have established and actively pursue intellectual property protection for our technology.
Discover how our siRNA based therapies work
Effective siRNA delivery to the right cells is a challenge given the complexity of the human body. Discover how we address this.
Find out more about our investment case, share price, corporate governance and related information. Download our latest reports and announcements.
View and download our Results, reports & presentations.
A summary of relevant information for our shareholders, investor FAQs and key adviser details.
Read more about our exisiting corporate governance arrangements.
AIM Rule 26 checklist.
Upcoming and past events.
All regulatory news.
Share price information and major shareholders.
Login or Register to our email alerts.
View our latest news, publications and videos here.
View our Latest News here.
View our Press Coverage here.
View our Publications here.
View our Videos here.